Disruption of cyclooxygenase type 2 exacerbates apoptosis and renal damage during obstructive nephropathy

Line Nilsson1, Kirsten Madsen2, Søren Krag3

  • 1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;

Insights

Cyclooxygenase-2 (COX-2) protects kidneys from tubular injury and apoptosis during ureteral obstruction. However, COX-2 is not essential for combating oxidative stress in this condition.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Ureteral obstruction elevates renal oxidative stress.
  • Cyclooxygenase-2 (COX-2) activity shows in vitro protective effects against oxidants.

Purpose of the Study:

  • To investigate the in vivo role of COX-2 in counteracting oxidative stress and apoptosis in obstructive nephropathy.
  • To determine if COX-2 activity is necessary for protection against tubular injury and oxidative damage following ureteral obstruction.

Main Methods:

  • Utilized COX-2 knockout (COX-2(-/-)) and wild-type (WT) mice subjected to unilateral ureteral obstruction (UUO) for 3 or 7 days.
  • Assessed renal oxidative stress markers (4-hydroxynonenal, nitrotyrosine), antioxidant enzymes (heme oxygenase-1, SOD2), and markers of tubular injury and apoptosis (kidney injury molecule-1, caspase-3).
  • Administered a selective COX-2 inhibitor, parecoxib, to WT mice undergoing sham operation or UUO.

Main Results:

  • COX-2 expression increased following UUO.
  • Oxidative stress markers were elevated in UUO kidneys without genotype differences.
  • COX-2 deletion aggravated tubular injury, evidenced by increased tubular dilatation, kidney injury molecule-1, caspase-3, and apoptosis.
  • Antioxidant enzymes heme oxygenase-1 and SOD2 showed higher levels in COX-2(-/-) mice, suggesting COX-2 does not directly regulate these enzymes.

Conclusions:

  • COX-2 is crucial for protecting renal tubules against injury and apoptosis in the context of ureteral obstruction.
  • COX-2 activity is not essential for mitigating the overall oxidative stress induced by ureteral obstruction.
  • The protective mechanism of COX-2 in obstructive nephropathy appears independent of direct regulation of heme oxygenase-1 and SOD.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
482
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.5K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K